Travere Therapeutics Inc. Common Stock (TVTX)

Stock · NASDAQ · Health Care

$65.67as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Support level

$27.63

Industry

Biotechnology: Pharmaceutical Preparations

Chosen by industry and closest market cap.

TVTX
Travere Therapeutics Inc. Common Stock
$65.67
▼ 2.74%
Market cap $5.11BP/E —
GRFS
Grifols S.A. American Depositary Shares
$7.68
▼ 1.79%
Market cap $5.40BP/E 13.31
$8.43$12.87
INDV
Indivior Pharmaceuticals Inc. Common Stock
$34.87
▼ 1.22%
Market cap $4.66BP/E 12.77
$22.22$42.81
PTCT
PTC Therapeutics Inc. Common Stock
$70.01
▼ 2.51%
Market cap $5.68BP/E —
$48.86$90.87
KNSA
Kiniksa Pharmaceuticals International plc Class A Ordinary Shares
$78.1
▼ 2.13%
Market cap $5.73BP/E 75.29
$33.25$82.94
DNTH
Dianthus Therapeutics Inc. Common Stock
$105.72
▼ 5.22%
Market cap $5.80BP/E —
$22.81$117.88
ACAD
ACADIA Pharmaceuticals Inc. Common Stock
$29.13
▼ 2.02%
Market cap $4.39BP/E 12.85
$19.69$30.96

Symbol	Market cap	P/E ratio	Price	1D	52-week range
TVTX Travere Therapeutics Inc. Common Stock	$5.11B	—	$65.67	▼ 2.74%
GRFS Grifols S.A. American Depositary Shares	$5.40B	13.31	$7.68	▼ 1.79%	$8.43$12.87
INDV Indivior Pharmaceuticals Inc. Common Stock	$4.66B	12.77	$34.87	▼ 1.22%	$22.22$42.81
PTCT PTC Therapeutics Inc. Common Stock	$5.68B	—	$70.01	▼ 2.51%	$48.86$90.87
KNSA Kiniksa Pharmaceuticals International plc Class A Ordinary Shares	$5.73B	75.29	$78.1	▼ 2.13%	$33.25$82.94
DNTH Dianthus Therapeutics Inc. Common Stock	$5.80B	—	$105.72	▼ 5.22%	$22.81$117.88
ACAD ACADIA Pharmaceuticals Inc. Common Stock	$4.39B	12.85	$29.13	▼ 2.02%	$19.69$30.96

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.